Business intelligence system
Menu

Early Access Public record report

Diabetology
in India.

A versioned evidence report describing 26,019 unique providers, geographic coverage, observable fields, and explicit limitations.
Explore industry Inspect methodology
Records
26,019
Source rows
27,683
Observed through
15 June 2026
Profile state
Early Access
Report version
2026-07-28.2
Publication ID
public:report:diabetology:india-public-record:v1
01

Coverage

What the projection
can currently describe.

Public address

25,71399% of public records

Website

12,69449% of public records

Coordinates

25,85999% of public records

Phone

19,29874% of public records

Email

5,82022% of public records

Rating

25,13697% of public records

Review count

23,49890% of public records

Missing fields are unknown or currently being enriched. They do not prove that the underlying business lacks the attribute.

02

Geography

Largest observed
state cohorts.

01Uttar Pradesh3,553
02Maharashtra1,905
03Rajasthan1,897
04Tamil Nadu1,531
05Madhya Pradesh1,480
06Bihar1,447
07Telangana1,354
08Karnataka1,313
09West Bengal1,187
10Andhra Pradesh1,042

This is record distribution, not provider density, demand, quality, revenue, or market share.

03

Freshness

Recently observed
public profiles.

-Dr.DEVENDRA KAUSHIK & Dr NEETA KAUSHIKShivpuri, Madhya Pradesh.Dr. Sunil PanwarShamli, Uttar Pradesh'D' ClinicsGuntur, Andhra Pradesh"Eva's Skin Care" Ajit hospitalMahendragarh, Haryana"Mithaas" - The Complete Diabetes Care Clinic (Dr Nilesh Tayade, MBBS, MD, PGD Diab., DBM)Buldhana, Maharashtra"RAKESH MULTISPECIALITY CLINIC" Dr Rakesh UkeyDurg, Chhattisgarh“Swasthayu" – Ayurvedic Doctor in Kanpur for Liver, Skin & Joint CareKanpur Dehat, Uttar Pradesh"USIRU" - The Breathe Clinic Dr.Ajith EtiDavangere, Karnataka
04

Evidence boundary

Versioned inputs.
No generated claims.

Population unit

unique providers

Identity method

Public projection deduplicated by production import provider identity.

Source evidence

Production diabetology import audit

AI status

No model generated or interpreted this report. Evidence-backed AI answers remain unavailable until the governed runtime is deployed.

Known limitations

  • The production import now has a public-safe Early Access projection, but it is not profile-certified.
  • Industry and business routes remain noindex until their owned promotion gates pass.